C9orf41 Activators are a class of chemicals characterized by their ability to directly or indirectly influence the activity of the C9orf41 protein through different biochemical pathways. The first method involves the manipulation of intracellular cAMP levels, for instance through Forskolin, which activates adenylate cyclase, or IBMX, a phosphodiesterase inhibitor. Another approach targets protein phosphorylation. Chemicals like PMA or Anisomycin activate protein kinase pathways that can lead to the activation of C9orf41. These mechanisms often involve secondary messengers like calcium, as in the case of Ionomycin and A23187, which both affect intracellular calcium levels.
Additionally, compounds like Resveratrol, Trichostatin A, and Okadaic Acid manipulate post-translational modifications like acetylation or phosphorylation. Epigenetic regulation is also a feasible method for C9orf41 modulation, as seen with HDAC inhibitors. Then there are chemicals that target broader cellular pathways but may have an impact on C9orf41. LY294002, a PI3K inhibitor, and Sodium Orthovanadate, a tyrosine phosphatase inhibitor, fall under this category. The chemicals thus employ a variety of cellular mechanisms to modulate the activity of C9orf41, such as alteration of secondary messenger levels, modification of enzyme activity, and epigenetic regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which can enhance C9orf41 activity if it is downstream of PKC signaling. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates SIRT1, which can modulate C9orf41 via deacetylation if it's a substrate or regulatory target of SIRT1. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases intracellular calcium concentration, potentially modulating C9orf41 if it's calcium-sensitive. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that maintains cAMP levels, possibly influencing C9orf41 if it is responsive to cAMP. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
JNK pathway activator. If C9orf41 is modulated by JNK-dependent phosphorylation, anisomycin can enhance its activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
PP2A inhibitor, maintains phosphorylation state of proteins, potentially activating C9orf41 if it is regulated by phosphorylation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor, altering chromatin state. Could activate C9orf41 if it is regulated epigenetically through histone modification. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, affecting C9orf41 indirectly if it’s regulated by the PI3K/AKT pathway. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that modulates intracellular calcium, potentially affecting C9orf41 if it's calcium-dependent. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Tyrosine phosphatase inhibitor, could activate C9orf41 if it's regulated by tyrosine phosphorylation. | ||||||